Voyager Therapeutics, Inc. - Common Stock (VYGR)

$4.12 0.00 (0.00%)

16:00 EST VYGR Stock Quote Delayed 30 Minutes

7 Biotech Stocks to Buy for Their Game-Changing Potential

By Josh Enomoto, InvestorPlace Contributor Aug 8, 2024

Although the market may be reeling from the recent fallout, the red ink presents a viable opportunity in these biotech stocks.

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

Volume:

Previous Close -

Market Cap 225.06M

PE Ratio -7.63

EPS -0.54

Volume (Avg. Vol.) 6

Day's Range -

52-Week Range $4.00 - $10.66

Dividend & Yield N/A (N/A)

VYGR Stock Predictions, Articles, and Voyager Therapeutics, Inc. - Common Stock News

Cheap Thrills: 7 Promising Value Stocks You Can Buy for Under $20

By Josh Enomoto, InvestorPlace Contributor Mar 21, 2024

If soaring consumer prices got you down, you may want to consider these value stocks under $20. Sure, the market may be booming during this…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Feb 29, 2024

It's time to dive into the biggest pre-market stock movers for Thursday as we check out all of the news affecting shares this morning!

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff

By Josh Enomoto, InvestorPlace Contributor Feb 26, 2024

While biotech stocks offer some of the most pertinent ideas available in the market, they can be awfully risky. One bad clinical result and boom…

Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024

By Yiannis Zourmpanos, InvestorPlace Contributor Jan 11, 2024

The 2024 investment trends are slowly making themselves known. Make sure you follow our guide to stay ahead of the curb.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jan 5, 2024

Pre-market stock movers are worth checking on Friday as we lay out all of the biggest stories worth keeping tabs on this morning!

VYGR Stock Alert: The $1.2 Billion Reason Voyager Therapeutics Is Up Today

By Dana Blankenhorn, InvestorPlace Contributor Jan 2, 2024

VYGR stock is in focus as analysts expect more pharma deals in 2024, although some think these deals will be sunk by the Biden administration.

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar

By Josh Enomoto, InvestorPlace Contributor Dec 17, 2023

With so many innovative firms skyrocketing this year, astute investors seeking compelling discounts may want to turn their attention to undervalued biotech picks. Just like…

Why These 7 Stocks Are the Best Ways to Play Biotech Right Now

By Josh Enomoto, InvestorPlace Contributor Jul 11, 2023

With biotech stocks offering myriad viable opportunities irrespective of broader conditions, this sector is worth a closer look.

The 7 Best Stocks Under $15 to Buy in June 2023

By Josh Enomoto, InvestorPlace Contributor Jun 1, 2023

While you generally get what you pay for, these best stocks under $15 for June provide compelling opportunities at discount.

7 A-Rated Stocks to Buy for Less Than $25

By Louis Navellier and the InvestorPlace Research Staff Jan 24, 2023

So, what are the best stocks to buy for less than $25 per share? Consider these seven. Each one earns an A rating in Portfolio Grader.

Voyager Therapeutics (VYGR) Stock Gains 18% on Gene Therapy Deal

By David Moadel, InvestorPlace Contributor Jan 9, 2023

Voyager Therapeutics' lucrative arrangement with a fellow biotech business is putting VYGR stock traders in a buying mood today.

7 Top-Rated Biotech Stocks to Buy for Q4

By Louis Navellier and the InvestorPlace Research Staff Sep 15, 2022

A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Oct 12, 2021

Good morning, investor! We're getting right into the thick of it today with a look at the biggest pre-market stock movers for Tuesday!

VYGR Stock: The Huge Licensing Deal Sending Voyager Therapeutics Rocketing Higher

By Chris MacDonald, InvestorPlace Contributor Oct 6, 2021

Here's the big licensing news that's sending shares of VYGR stock higher today as investors reassess this company's value moving forward.

7 Stocks for Value Investors to Buy Near Their 52-Week Lows

By Mark R. Hake, CFA Mar 23, 2021

Sometimes a selloff is a sign of more pain to come, but these are 7 stocks to buy if you think a rebound may be close at hand.

10 High-Growth Stocks Every Young Investor Should Own

By Josh Enomoto, InvestorPlace Contributor Sep 3, 2020

Young investors can leverage their extra time to bet on high-growth stocks that are likely to jump on developing trends.

3 Top Gene Therapy Stocks That Could Soar

By Aaron Levitt, InvestorPlace Contributor May 30, 2019

Biotech stocks targeting gene therapy are going to be huge. Here are 3 gene therapy stocks to buy that have a ton of potential.

7 Cheap Biotech Stocks to Buy Now

By Anthony Mirhaydari, InvestorPlace Market Strategist Aug 23, 2018

These biotech stocks are set for a strong comeback as investors start to walk away from large-cap tech companies. Here's what investors need to know about each company.

7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.

By Harriet Lefton, Writer, TipRanks Jun 13, 2018

Here we dig down into seven intriguing stock rating upgrades from the Street. Why now? Why are analysts turning bullish on these stocks? All seven of these stocks share a 'Strong Buy' analyst consensus rating from the Street. The result: you can be confident that these stocks are the crème de la crème.

3 Stocks to Watch on Tuesday: Mondelez International Inc (MDLZ), SBA Communications Corporation (SBAC) and Voyager Therapeutics Inc (VYGR)

By Karl Utermohlen, InvestorPlace Writer Oct 31, 2017

Mondelez (MDLZ) and SBA Communications (SBAC) posted earnings, while Voyager Therapeutics (VYGR) issued an update on its Parkinson's drug.

Voyager Therapeutics, Inc. - Common Stock (VYGR)

7 Biotech Stocks to Buy for Their Game-Changing Potential

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q2 2024

VYGR Stock Earnings: Voyager Therapeutics Beats EPS, Beats Revenue for Q1 2024

The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Voyager Therapeutics, Inc. - Common Stock (VYGR)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VYGR Stock Predictions, Articles, and Voyager Therapeutics, Inc. - Common Stock News

Subscriber Sign in